C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 277/00 (2006.01)
Patent
CA 2554888
The present invention relates to 5-[[4-[2-(methyl-2- pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione phosphate, a novel salt of rosiglitazone and to novel polymorphic forms thereof. The invention is also directed to processes for preparation of rosiglitazone phosphate and its polymorphs. The compounds of the invention are useful for treatment and/or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and certain complications thereof.
La présente invention a trait à 5-[[4-[2-(méthyl-2-pyridinylamino)éthoxy]phényl]méthyl]-2,4-thiazolidinedione phosphate, un nouveau sel de rosiglitazone et à de nouvelles formes polymorphes de celui-ci. L'invention a également trait à des procédés de préparation de phosphate de rosiglitazone et ses formes polymorphes. Les composés de l'invention sont utiles pour le traitement et/ou la prophylaxie du diabète sucré, des conditions associées au diabète sucré et à certaines complications en découlant.
Greil Julia
Ludescher Johannes
Wolf Siegfried
Fetherstonhaugh & Co.
Sandoz Ag
LandOfFree
Rosiglitazone phosphate and polymorphic forms does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rosiglitazone phosphate and polymorphic forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rosiglitazone phosphate and polymorphic forms will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2034619